Skip to main content
Clinical Trials/ISRCTN38470689
ISRCTN38470689
Active, not recruiting
未知

Maternal hyperoxygenation in diagnostic fetal imaging

King's College London0 sites200 target enrollmentApril 1, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Other obstetric conditions, not elsewhere classified
Sponsor
King's College London
Enrollment
200
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2020
End Date
May 31, 2022
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Women with a pregnancy at 18 weeks or later at the time of scan
  • 2\. 18 years of age and over
  • 3\. Can read the information sheet and understand the purpose of the study and what it would entail

Exclusion Criteria

  • 1\. Maternal weight \> 125kg
  • 2\. Maternal claustrophobia
  • 3\. Patients in the first trimester of pregnancy
  • 4\. Use of any of the following medication: adriamycine, bleomycine, actinomycine, menadion, chlorpromazine, thiordiazine, chloroquine
  • 5\. Severe maternal respiratory pathology
  • 6\. Unable to give informed consent
  • 7\. Contra\-indication to MRI
  • Healthy controls
  • 8\. Fetal growth restriction
  • 9\. Fetal congenital anomaly

Outcomes

Primary Outcomes

Not specified

Similar Trials